Showing results (21-30 of 235) with videos related to

Sort By:
Pageof 24
Neurotoxicity Research|January 27, 2017
Investigation of Cuprizone Inactivation by TemperatureSandra Heckers, Nadine Held, Jessica Kronenberg, et al.
Fluids and Barriers of the CNS|September 6, 2019
Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathyNora Möhn, Yi Luo, Thomas Skripuletz, et al.
Neurological Research and Practice|June 28, 2023
Alzheimer's disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °CFranz Felix Konen, Hannah Benedictine Maier, Alexandra Neyazi, et al.
Frontiers in Immunology|June 2, 2020
Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERSNora Möhn, Refik Pul, Christoph Kleinschnitz, et al.
Glia|July 17, 2023
Dynamics of reactive astrocytes fosters tissue regeneration after cuprizone-induced demyelinationLara-Jasmin Schröder, Felix Mulenge, Andreas Pavlou, et al.
Plos One|July 30, 2010
Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouseDarius Moharregh-Khiabani, Alexander Blank, Thomas Skripuletz, et al.
Therapeutic Advances in Neurological Disorders|January 30, 2023
Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis - a review of population-specific evidence from randomized clinical trialsAntonios Bayas, Monika Christ, Simon Faissner, et al.
Neurobiology of Disease|October 6, 2011
Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?Elke Verena Voss, Jelena Škuljec, Viktoria Gudi, et al.
Molecular Medicine Reports|August 5, 2015
Effect of FTY720-phosphate on the expression of inflammation-associated molecules in astrocytes in vitroStefanie Janssen, Caroline Schlegel, Viktoria Gudi, et al.
Neuroscience Letters|September 7, 2010
Interferon-β treatment normalises the inhibitory effect of serum from multiple sclerosis patients on oligodendrocyte progenitor proliferationAlexandra Kotsiari, Elke Verena Voss, Refik Pul, et al.
Pageof 24